Display options
Cite
Warner MR, Rappaport MS, Krieger NS, et al. Ametantrone inhibits prostaglandin--mediated resorption in bone organ culture. Prostaglandins. 1984;28(4):469-76doi: 10.1016/0090-6980(84)90235-1.
Warner, M. R., Rappaport, M. S., Krieger, N. S., Novak, R. F., & Stern, P. H. (1984). Ametantrone inhibits prostaglandin--mediated resorption in bone organ culture. Prostaglandins, 28(4), 469-76. https://doi.org/10.1016/0090-6980(84)90235-1
Warner, M R, et al. "Ametantrone inhibits prostaglandin--mediated resorption in bone organ culture." Prostaglandins vol. 28,4 (1984): 469-76. doi: https://doi.org/10.1016/0090-6980(84)90235-1
Warner MR, Rappaport MS, Krieger NS, Novak RF, Stern PH. Ametantrone inhibits prostaglandin--mediated resorption in bone organ culture. Prostaglandins. 1984 Oct;28(4):469-76. doi: 10.1016/0090-6980(84)90235-1. PMID: 6335259.
Copy Download .nbib Format: NLM
Share it on

Prostaglandins. 1984 Oct;28(4):469-76. doi: 10.1016/0090-6980(84)90235-1.

Ametantrone inhibits prostaglandin--mediated resorption in bone organ culture.

Prostaglandins

M R Warner, M S Rappaport, N S Krieger, R F Novak, P H Stern

PMID: 6335259 DOI: 10.1016/0090-6980(84)90235-1

Abstract

Prostaglandins (PG) have been postulated to be involved in both tumor metastases to bone and in tumor-induced bone resorption. The anthracenedione antineoplastic agents ametantrone (HAQ) and mitoxantrone are potent antioxidants and inhibit hydroperoxide-dependent initiation and propagation reactions. Therefore, these compounds may inhibit PG production and could also inhibit tumor metastases and tumor-induced resorption. The ability of HAQ, a prototypic anthracenedione, to inhibit PG synthesis and PG-mediated bone resorption was investigated using neonatal mouse calvaria in organ culture. Epidermal growth factor (EGF) stimulates bone resorption in this tissue by inducing PG synthesis. Consequently, if HAQ inhibits EGF-stimulated PG synthesis, it should also inhibit EGF-stimulated bone resorption. HAQ, at 10 microM, completely abolished EGF-stimulated PG synthesis and calcium release. Moreover, HAQ (1.0-30 microM) inhibition of EGF-stimulated PGE2 synthesis correlated with the inhibition of EGF-stimulated Ca release in a concentration-dependent manner. In contrast to EGF, parathyroid hormone stimulates resorption by a PG-independent pathway. HAQ at 10 microM had no effect on parathyroid hormone stimulated Ca release. These results suggest that HAQ inhibition of bone resorption appears to be primarily mediated by inhibition of PG biosynthesis.

Substances

MeSH terms

Publication Types

Grant support

LinkOut - more resources